Hao Ding
Impact in
- Urology top 10%
- Periodontal Regeneration and Treatments
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Oncology 12
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3
- Viral-associated cancers and disorders 2
- Co-authors
- Weifeng Tang (7 shared papers)Ari Gafni (1 shared paper)Pamela T. Wong (1 shared paper)Hao Qiu (5 shared papers)D. G. Steel (1 shared paper)Changqing Zhang (2 shared papers)Guangyi Li (1 shared paper)Weitao Jia (1 shared paper)
- Journals
- Oncotarget (6 papers)Cancer Chemotherapy and Pharmacology (2 papers)Frontiers in Oncology (2 papers)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hao Ding
31 papers receiving 367 citations
Peers
Comparison fields: 5 of 78
- Urology 33
- Cancer Research 53
- Oncology 86
- Molecular Biology 157
- Pathology and Forensic Medicine 41
Countries citing papers authored by Hao Ding
This map shows the geographic impact of Hao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Ding more than expected).
Fields of papers citing papers by Hao Ding
This network shows the impact of papers produced by Hao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Ding. The network helps show where Hao Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 62 | |
| 2 | 2012 | 48 | |
| 3 | 2013 | 40 | |
| 4 | 2017 | 19 | |
| 5 | 2017 | 16 | |
| 6 | 2020 | 15 | |
| 7 | 2025 | 13 | |
| 8 | 2017 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2018 | 12 | |
| 11 | 2019 | 12 | |
| 12 | 2012 | 11 | |
| 13 | 2018 | 10 | |
| 14 | 2020 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2013 | 8 | |
| 20 | 2019 | 8 |
About Hao Ding
Hao Ding is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 33 papers that have together received 372 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Lymphoma Diagnosis and Treatment (4 papers), RNA modifications and cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Circular RNAs in diseases (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), MicroRNA in disease regulation (3 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Urology (33 citations), Cancer Research (53 citations), Oncology (86 citations), Molecular Biology (157 citations) and Pathology and Forensic Medicine (41 citations). Hao Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weifeng Tang, Ari Gafni, Pamela T. Wong, Hao Qiu, D. G. Steel, Changqing Zhang, Guangyi Li, Weitao Jia, Haiyong Gu and Bin Sun. Their work appears in journals such as Oncotarget, Cancer Chemotherapy and Pharmacology, Frontiers in Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.